![Miguel Fernandez](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Oorsprong van het eerstegraads netwerk van Miguel Fernandez
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
Teva Spanish Holdco, Inc.
![]() Teva Spanish Holdco, Inc. Pharmaceuticals: MajorHealth Technology Teva Spanish Holdco, Inc. manufactures, markets, and distributes pharmaceutical products. It specializes in offering treatment for cardiovascular, gastrointestinal, infectious, and neurological diseases. The firm was founded in 1974, and is headquartered in Exeter, NH.
12
| Subsidiary | Pharmaceuticals: Major | 12 |
CPEX Pharmaceuticals, Inc.
![]() CPEX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology CPEX Pharmaceuticals, Inc. is engaged in the development, licensing and commercialization of pharmaceutical products utilizing its validated drug delivery technology. Its technology enhances permeation and absorption of pharmaceutical molecules across the skin, nasal mucosa and eye through formulation development with proprietary molecules such as CPE-215. The company's first product is Testim, a gel for testosterone replacement therapy, which is a formulation of its technology with testosterone. Testim is licensed to Auxilium Pharmaceuticals, Inc., which is currently marketing it in the United States, Europe and other countries. Its other product is Nasulin, which is an intranasal formulation of insulin being developed to treat hyperglycemia in patients suffering from Type 1 and Type 2 diabetes. The company was founded on September 28, 2007 and is headquartered in Exeter, NH.
8
| Extinct | Pharmaceuticals: Major | 8 |
MedPointe, Inc.
![]() MedPointe, Inc. Pharmaceuticals: MajorHealth Technology MedPointe, Inc. develops, markets, and sells therapeutics. The company's products include respiratory, allergy, central nervous system, cough/cold, and pediatric products. The company was founded by James S. Burns and Anthony H. Wild in 2001 and is headquartered in Somerset, NJ.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Miguel Fernandez via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
Centeon LLC | Chief Executive Officer Chief Tech/Sci/R&D Officer | ||
Purdue University | College/University | Doctorate Degree Doctorate Degree | |
University of Michigan | College/University | Graduate Degree Masters Business Admin | |
R.J. Reynolds Tobacco Holdings, Inc.
![]() R.J. Reynolds Tobacco Holdings, Inc. TobaccoConsumer Non-Durables R.J. Reynolds Tobacco Holdings, Inc. manufactures and markets cigarettes and tobacco products. The company was founded in 1970 and is headquartered in Winston-Salem, NC. | Tobacco | President Director of Finance/CFO | |
Rutgers State University of New Jersey | College/University | Graduate Degree Undergraduate Degree | |
Carter-Wallace, Inc. /Antiperspirant & Pet Care Operations/ | Household/Personal Care | General Counsel Corporate Officer/Principal | |
Affyimmune Therapeutics, Inc.
![]() Affyimmune Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Affyimmune Therapeutics, Inc. engages in the development of engineered immune cells to fight cancer disease. The company was founded by Gang Song on August 16, 2016 and is headquartered in Natick, MA. | Miscellaneous Commercial Services | Director/Board Member | |
IDRx, Inc.
![]() IDRx, Inc. Miscellaneous Commercial ServicesCommercial Services IDRx, Inc. is a clinical-stage biopharmaceutical company located in an undisclosed location. The American company is dedicated to transforming cancer care with intelligently designed precision therapies. IDRx aims to address the limitations of today's precision cancer medicines with highly potent and selective targeted therapies to stop key tumor escape mechanisms and prolong response to therapy. The company's pipeline programs include small molecule tyrosine kinase inhibitors, and idrx-73, designed to inhibit key genetic drivers and drug-resistant mutations of gastrointestinal stromal tumor (GIST). IDRx was founded in 2021 by Alexis A. Borisy, Nicholas B. Lydon, Ben Auspitz, George D. Demetri, and Robert M. Forrester. Ben Auspitz has been the CEO since incorporation. | Miscellaneous Commercial Services | Founder | |
EQRX, INC. | Pharmaceuticals: Major | Founder | |
EQRx International, Inc.
![]() EQRx International, Inc. Pharmaceuticals: MajorHealth Technology EQRx International, Inc. engages in healthcare services. The firm specializes in remaking medicine services. The company was founded by Peter Bach and Sandra Horning on January 12, 2020 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder | |
Deciduous Therapeutics, Inc.
![]() Deciduous Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Deciduous Therapeutics, Inc. engages in the biotechnology business. It develops novel therapies to activate the endogenous immune system to treat age related diseases. The company is headquartered in San Francisco, CA. | Pharmaceuticals: Major | Director/Board Member | |
Pillar Biosciences, Inc.
![]() Pillar Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Pillar Biosciences, Inc. is a clinical cancer diagnostics company. The firm engages in the creation of precision NGS panels and software solutions. It offers solid tumor panels, blood cancer panels, inherited disease panels, and custom panels. The company was founded by Gang Song and Zhaohui Wang in 2014 and is headquartered in Natick, MA. | Pharmaceuticals: Major | Director/Board Member | |
Brixton Biosciences, Inc.
![]() Brixton Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Brixton Biosciences, Inc. has developed coolio™ therapy, an injection that provides long-lasting pain relief as an alternative to opioids. The company is based in Cambridge, MA and was founded by Robert M. Forrester and Sameer A. Sabir. The therapy is designed to desensitize pain in a targeted area and has the potential to eradicate the pain of pain. | Miscellaneous Commercial Services | Founder | |
The University of Law Ltd. | College/University | Graduate Degree | |
IMMUNOMEDICS, INC. | Biotechnology | Director/Board Member | |
SevenOaks Biosystems LLC
![]() SevenOaks Biosystems LLC Medical SpecialtiesHealth Technology Part of Medline Industries LP (Illinois), SevenOaks Biosystems LLC is a company that develops medical devices. The company is based in Cambridge, MA. The company was founded by Richard Rox Anderson, Sameer A. Sabir. SevenOaks Biosystems was acquired by Medline Industries LP (Illinois) on November 30, 2016. | Medical Specialties | Director/Board Member | |
GELESIS INC | Biotechnology | Director/Board Member | |
VERASTEM, INC. | Biotechnology | Chief Executive Officer | |
AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
STERIS CORP | Medical Specialties | Chief Tech/Sci/R&D Officer | |
Seton Hall University | College/University | Graduate Degree | |
St. John's University | College/University | Doctorate Degree | |
The Great Lakes Science Center
![]() The Great Lakes Science Center Other Consumer ServicesConsumer Services The Great Lakes Science Center operates as a museum and educational facility in downtown Cleveland. The company is headquartered in Cleveland, OH. | Other Consumer Services | Director/Board Member | |
Iona College | College/University | Undergraduate Degree | |
AVON PRODUCTS, INC. | Household/Personal Care | President | |
Rhapsody Biologics, Inc.
![]() Rhapsody Biologics, Inc. BiotechnologyHealth Technology Rhapsody Biologics, Inc. develops a personalized peptide vaccine platform. It predicts and optimizes peptide vaccines for use at an individual and population level. Its platform technology encompasses a discovery system to identify immunogenic fragments of disease causing agents that will stimulate an immune response. The company was founded by Richard Paul Kivel and Ren Ee Chee in October 2009 and is headquartered in Norwell, MA. | Biotechnology | Director/Board Member | |
Coley Pharmaceutical Group, Inc.
![]() Coley Pharmaceutical Group, Inc. Pharmaceuticals: MajorHealth Technology Coley Pharmaceutical Group, Inc. manufactures drugs to treat chronic diseases. The company discovers and develops receptors therapeutic candidates for cancers, asthma, and allergic disorders. It was founded in 1997 and is headquartered in Wellesley, MA | Pharmaceuticals: Major | Director of Finance/CFO | |
MYREXIS, INC. | Financial Conglomerates | Director/Board Member | |
FORMA Therapeutics, Inc.
![]() FORMA Therapeutics, Inc. BiotechnologyHealth Technology FORMA Therapeutics, Inc. discovers and develops medicines for cancer and other genetically driven diseases. Its drug discovery engine deploys screening and structure-based approaches across broad families of targets involved in tumor metabolism, epigenetics, protein homeostasis, and protein-protein interactions. The company was founded by Steven Tregay, Nikolai Kley, Stuart L. Schreiber, Todd R. Golub, Michael Foley and Alexis Borisy in 2008 and is headquartered in Watertown, MA. | Biotechnology | Chief Operating Officer | |
University of Bristol | College/University | Graduate Degree | |
Eyecool Therapeutics, Inc.
![]() Eyecool Therapeutics, Inc. Medical SpecialtiesHealth Technology Eyecool Therapeutics, Inc. develops novel device-based technology for the treatment of dry eye. The company is based in Cambridge, MA. | Medical Specialties | Director/Board Member | |
Atlantic Healthcare Plc
![]() Atlantic Healthcare Plc Pharmaceuticals: MajorHealth Technology Atlantic Healthcare Plc operates as holding company with interest in pharmaceutical. Its products include Alicaforsen Enema, an anti-inflammatory intercellular adhesion molecule inhibitor that acts by inhibiting a key protein in the inflammation process. The firm offers its product for the treatment of pouchitis and ulcerative colitis. The company was founded by Toby Wilson Waterworth and Fiona Mary Wilson Waterworth in 2006 and is headquartered in Saffron Walden, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
Sandoz, Inc.
![]() Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Chief Executive Officer | |
OnCusp Therapeutics6
![]() OnCusp Therapeutics6 Miscellaneous Commercial ServicesCommercial Services OnCusp Therapeutics is a biotechnology company based in New York, NY and has subsidiaries in China. OnCusp Therapeutics specializes in developing preclinical assets to clinical proof of concept and then partnering out for commercialization in the field of oncology therapeutics. The company is committed to accelerating the advancement of oncology assets by leveraging its deep translational and clinical development expertise. OnCusp Therapeutics is backed by prominent investors including Sequoia Capital, Biotrack Capital, Oriza Seed Capital, and AIHC Capital. The company was founded in 2021 by Andy Fu, Bing Yuan, and Eric Slosberg, with Bing Yuan serving as the CEO since then. | Miscellaneous Commercial Services | Director/Board Member | |
BTG International Ltd.
![]() BTG International Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Boston Scientific Corp., BTG International Ltd. is a British company that engages in research and experimental development on natural sciences and engineering. The company is based in London, UK and was founded in 1991. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
AdipoGenix, Inc.
![]() AdipoGenix, Inc. Pharmaceuticals: MajorHealth Technology AdipoGenix, Inc. develops molecular pharmaceutical products. It offers small molecule pharmaceuticals to treat obesity and its co-morbidities. The firm’s technology includes AdipoBASE, AdipoSCREEN, AdipoPATH and AdipoTARGET. The company was founded by Gerri Waloga, Barbara E. Corkey, Stephen R. Farmer, James A. Hamilton, James L. Kirkland, H. Jeff Leighton and Paul F. Pilch in 1997 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Egenix, Inc.
![]() Egenix, Inc. BiotechnologyHealth Technology Part of Denan, Inc., Egenix, Inc. engages in cancer therapeutics research and development. The company is based in Millbrook, NY. Egenix was acquired by Denan, Inc. on June 10, 2015 for $0.82 million. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Deloitte & Touche LLP
![]() Deloitte & Touche LLP Miscellaneous Commercial ServicesCommercial Services Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Comptroller/Controller/Auditor | |
Merrimack College | College/University | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 43 |
Verenigd Koninkrijk | 6 |
Frankrijk | 2 |
Canada | 2 |
Kaaimaneilanden | 2 |
Sectoraal
Health Technology | 24 |
Consumer Services | 11 |
Commercial Services | 8 |
Finance | 6 |
Consumer Non-Durables | 4 |
Operationeel
Director/Board Member | 63 |
Corporate Officer/Principal | 29 |
Undergraduate Degree | 18 |
Director of Finance/CFO | 18 |
Chief Tech/Sci/R&D Officer | 17 |
Sterkste connecties
- Beurs
- Insiders
- Miguel Fernandez
- Bedrijfsconnecties